lncRNAs expression among various types of cancer involved in The Cancer Genome Atlas based on GEPIA. (A) ADAMTS9-AS1, (B) WT1-AS, (C) LINC00536, (D) SRGAP3-AS2, (E) PWRN1 and (F) C10orf126. There is no description of the genes AC061992.1, AL391421.1, AC007731.1 and AL513123.1 in GEPIA. The y-axis indicates the log2 (transcripts per million + 1) for lncRNA expression. Red-colored bars represent the tumor tissue samples and the green-colored bars indicate the normal tissue samples. These charts were derived from GEPIA. lncRNAs; long non-coding RNAs; GEPIA, Gene Expression Profiling Interactive Analysis; KIRC, kidney renal clear cell carcinoma; KIRP, kidney renal papillary cell carcinoma; PRAD, prostate adenocarcinoma; LAML, acute myeloid leukemia; OV, ovarian cancer; UCEC, uterine corpus endometrial carcinoma; UCS, uterine carcinosarcomas; BRCA, breast invasive carcinoma; TGCT, testicular germ cell tumors; ACC, adenoid cystic carcinoma; CHOL, cholangiocarcinoma; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma; THCA, thyroid carcinoma; PCPG, pheochromocytoma and paraganglioma; LIHC, liver hepatocellular carcinoma. ADAMTS9-AS1, ADAM metallopeptidase with thrombospondin type 1 motif 9-antisense RNA 1; WT1-AS, Wilms tumor 1 antisense RNA; LINC00536, long intergenic non-protein coding RNA 536; SRGAP3-AS2, SLIT-ROBO Rho GTPase activating protein 3 antisense RNA 2; PWRN1, Prader-Willi region non-protein coding RNA 1; C10orf126, chromosome 10 open reading frame 126.